Status:
COMPLETED
Viral Triggers in Pediatric Lung Transplantation
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Transplant
Bronchiolitis Obliterans
Eligibility:
All Genders
Up to 21 years
Brief Summary
The purpose of this study is to determine whether respiratory viral infections increase the risk of bronchiolitis obliterans syndrome (BOS), obliterative bronchiolitis (OB), death, or retransplantatio...
Eligibility Criteria
Inclusion
- Parent or legal guardian willing and able to provide informed consent
- Participant of first single or bilateral heart-lung transplant
Exclusion
- Recipient of multi-organ transplant (aside from heart-lung)
- Condition or characteristic which in the opinion of the investigator makes the participant unlikely to complete the study
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00891865
Start Date
June 1 2009
End Date
April 1 2015
Last Update
July 2 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305
2
Children's Hospital Boston
Boston, Massachusetts, United States
3
Washington University
St Louis, Missouri, United States, 63110
4
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205